Trends in the Lifetime Risk of Developing Cancer in Ontario, Canada

Similar documents
Modelled prevalence. Marc COLONNA. January 22-23, 2014 Ispra

Answer keys for Assignment 4: Measures of disease frequency

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer

Trends in colorectal cancer incidence in younger Canadians,

Estimating Incidence of HIV with Synthetic Cohorts and Varying Mortality in Uganda

Report on Cancer Statistics in Alberta. Kidney Cancer

Report on Cancer Statistics in Alberta. Melanoma of the Skin

Report on Cancer Statistics in Alberta. Breast Cancer

DAILY SMOKERS - AVERAGE NUMBER OF CIGARETTES SMOKED DAILY KEY MESSAGES

Survival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer

Liver Cancer Report on Cancer Statistics in Alberta. December Cancer Care. Cancer Surveillance

Kidney Cancer Report on Cancer Statistics in Alberta. December Cancer Care. Cancer Surveillance

Leukemia Report on Cancer Statistics in Alberta. December Cancer Care. Cancer Surveillance

1.4 - Linear Regression and MS Excel

Colorectal Cancer Report on Cancer Statistics in Alberta. December Cancer Care. Cancer Surveillance

Spatiotemporal models for disease incidence data: a case study

Calibrating Time-Dependent One-Year Relative Survival Ratio for Selected Cancers

Immunization Safety Office: Overview and Considerations on Safety of Alternative Immunization Schedules

Summary Report Report on Cancer Statistics in Alberta. February Surveillance and Health Status Assessment Cancer Surveillance

Measures of association: comparing disease frequencies. Outline. Repetition measures of disease occurrence. Gustaf Edgren, PhD Karolinska Institutet

Lifetime vs. 10-year risk to allocate treatments for the primary prevention of cardiovascular disease

2012 Report on Cancer Statistics in Alberta

Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers

Statistical techniques to evaluate the agreement degree of medicine measurements

ALL CANCER (EXCLUDING NMSC)

Estimating and comparing cancer progression risks under varying surveillance protocols: moving beyond the Tower of Babel

ALL CANCER (EXCLUDING NMSC)

MULTIPLE REGRESSION OF CPS DATA

1. Heavy drinking amongst adults in Toronto remained fairly stable from 2007 to 2014.

Methodology for the Survival Estimates

CLINICAL ASSISTED REPRODUCTION

Cigarette smoking is the number one cause of preventable death and disease in Ontario. Smoking kills half of its long-term users.

To quantify the average lifetime according to health status among the oldest-old

Supplementary Online Content

National Cancer Institute

The relationship between place of residence and postpartum depression

2012 Report on Cancer Statistics in Alberta

The Impact of E-Path Technology on the Ontario Cancer Registry. Operations

burden of tobacco Key Findings about the Use and Consequences of Tobacco in Peel

ASSESSMENT OF LEAD-TIME BIAS IN ESTIMATES OF RELATIVE SURVIVAL FOR BREAST CANCER

Reading and maths skills at age 10 and earnings in later life: a brief analysis using the British Cohort Study

A Study on Type 2 Diabetes Mellitus Patients Using Regression Model and Survival Analysis Techniques

Dose-Response Relationship of Essential Metallic Elements. The Application of Categorical Regression Example: Copper

Public Health Masters (MPH) Competencies and Coursework by Major

Analysis of Waiting-Time Data in Health Services Research

10. LINEAR REGRESSION AND CORRELATION

Overview. All-cause mortality for males with colon cancer and Finnish population. Relative survival

Rare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers,

A Bayesian Perspective on Unmeasured Confounding in Large Administrative Databases

Estimating Testicular Cancer specific Mortality by Using the Surveillance Epidemiology and End Results Registry

Webinar: How Do We Measure Mental Illness & Addictions at a Population Level?

The epidemiology of hepatitis C infection in Ontario, 2004

Advanced IPD meta-analysis methods for observational studies

New HIV diagnoses in Ontario: Preliminary update, 2016

Common Misunderstandings of Survival Time Analysis

etable 3.1: DIABETES Name Objective/Purpose

Types of data and how they can be analysed

Liver cancer and immigration: small-area analysis of incidence within Ottawa and the Greater Toronto Area, 1999 to 2003.

AP Statistics. Semester One Review Part 1 Chapters 1-5

Estimating and modelling relative survival

Future smoking-attributable and all-cause mortality: its sensitivity to indirect estimation techniques

Variation in optimal pre-diagnostic pathway in lung cancer patients in 2013 & 2014 using cancer registrations and the diagnostic imaging dataset

Cancer incidence in the United Kingdom: projections to the year 2030

Cancers attributable to excess body weight in Canada in D Zakaria, A Shaw Public Health Agency of Canada

Supplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time.

Physician On-line Staging Application. Darlene Dale Head, PMH Cancer Registry

The effect of immune conditions on pesticide use and the risk of non- Hodgkin lymphoma. Manisha Pahwa, OCRC CARWH Conference June 2, 2012

Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis Bayoumi A M, Redelmeier D A

Investigation of relative survival from colorectal cancer between NHS organisations

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women

Multivariate dose-response meta-analysis: an update on glst

SMOKING STAGES OF CHANGE KEY MESSAGES

Multiple Trait Random Regression Test Day Model for Production Traits

Cancer prevalence. Chapter 7

Diabetes in New Zealand Models and Forecasts

Original Article Downloaded from jhs.mazums.ac.ir at 22: on Friday October 5th 2018 [ DOI: /acadpub.jhs ]

BIOSTATISTICAL METHODS AND RESEARCH DESIGNS. Xihong Lin Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA

Yukon Palliative Care Framework

Supplementary Appendix

Manitoba Annual Immunization Surveillance Report

Staging Tool. Simplifies the Collection of Valid UICC-TNM Staging Data for the Princess Margaret Cancer Registry NAACCR 2014

Setting The setting was secondary care. The study was carried out in the UK, with emphasis on Scottish data.

Biostatistics II

Analysis of Persistency of Lactation Calculated from a Random Regression Test Day Model

Statistical Science Issues in HIV Vaccine Trials: Part I

Defining and Measuring Recent infection

Table 2.3. Cohort and nested case-control studies of nickel and lung cancer

An Overview of Survival Statistics in SEER*Stat

Mohammad Hajizadeh McGill University PHO-Rounds: Epidemiology 15 August 2013

HEALTH EFFECTS OF PRESERVED WOOD: RELATIONSHIP BETWEEN CCA- TREATED WOOD AND INCIDENCE OF CANCER IN THE UNITED STATES. Daniel C.

Cancer in Huron County

Timing of vaccination campaigns against pandemic influenza in a population dynamical model of Vancouver, Canada

Modelling Diabetes: A multi-state life table model

Introduction to Statistical Methods for Clinical Trials

STATISTICAL APPENDIX

< N=248 N=296

Evidence Based Considerations for Adult Mosquito Control

Data Then and Now. What do your Numbers Mean?

Cancer survival and prevalence in Tasmania

Rinku Sutradhar Page 1

Transcription:

Trends in the Lifetime Risk of Developing Cancer in Ontario, Canada Huan Jiang 1,2, Prithwish De 1, Xiaoxiao Wang 2 1 Surveillance and Cancer Registry, Analytic and Informatics, Cancer Care Ontario 2 Dalla Lana School of Public Health, University of Toronto June 14, 2016 1 of 22

Outline 1 2 3 4 5 6 2 of 22

Outline 1 2 3 4 5 6 3 of 22

The lifetime risk reflects the risk over the course of a person s lifetime The lifetime risk of developing cancer of 1 in 2 is a commonly cited cancer statistics The risk is estimated based on a population s experience with developing cancer or dying from cancer Cancer incidence and mortality rates are closely monitored to track the burden of cancer and its evolution in populations in Ontario 4 of 22

Research Objectives 1) Calculate the estimates of the lifetime risk of developing cancers in Ontario for a birth cohort born from 50s to 80s 2) Compare the estimates using current probability method with cumulative risk method To do this, one needs to project cancer incidence and mortality rates, as well as the population growth up to year of 2067 5 of 22

Data Sources Cancer data from year 1969 to 2012 were retrieved from the Ontario Cancer Registry, a population-based registry of all cancer cases and deaths in Ontario Forecasted population counts by five-year age groups from age 0-4 to 90+ for the years 2013 to 2041 were obtained from the Ontario Ministry of Finance 6 of 22

Outline 1 2 3 4 5 6 7 of 22

Age-Period-Cohort Regression Model for Projections R a,p = (A a + P p + C c + D p ) 5 The APC model is modified slightly: Instead of standard log link, a power 5 link function is used The coefficients are to be estimated for age (A), period (P), cohort (C) and drift (D) Due to colinearity among age, period and cohort, linear effects of period and cohort cannot be estimate simultaneously a common linear trend ( drift ) is estimated instead Predictions assume future period effects are equal to last estimated effect in the fitted model 8 of 22

Prediction of Population Spline smoothing is used to predict population counts from year 2043 to 2067; The method applies spline function to fit a smooth curve to the set of observed data points 9 of 22

Lifetime Risk Estimate Current probability method to estimate the lifetime risk Sˆ 0 (i) =exp( i j =0 λ i =r i + m i d i (λ j )) l i = ˆ S 0 (i) r i 1 exp( λ i) λ i l i : the contribution to the life time risk at age group i Sˆ 0 (i): the probability of being at risk(ie alive and without a previous diagnosis of cancer) at age group i λ i : the hazard of no longer being alive and cancer free r i : incidence of all cancers m i : all-causes mortality rates d i : cancer mortality rate 10 of 22

Outline 1 2 3 4 5 6 11 of 22

Results of Incidence Projections Figure: Incidence projections for all cancer combined (1968-2067) Predicted cancer incidences increase with years Men have a higher cancer incidence than women 12 of 22

Results of All-Cancer Mortality Projections Figure: All cancer mortality predictions (1968-2067) Predicted mortalities varies by the options being chosen The recent reduced option was chosen 13 of 22

Results of Mortality Projections Figure: All cause mortality predictions (1968-2067) The low option was chosen to reflect the improvement in mortality seen over recent years 14 of 22

Population growth over years by selected age groups A moderate increase in population is assumed 15 of 22

Outline 1 2 3 4 5 6 16 of 22

The comparison for the lifetime risk estimations Comparing with the current probability method, the cumulative probability method tends to overestimate the lifetime risk of cancer 17 of 22

Outline 1 2 3 4 5 6 18 of 22

with Different Model Assumptions 19 of 22

Outline 1 2 3 4 5 6 20 of 22

Cumulative risk method tends to overestimate the lifetime risk of cancer The lifetime risk of having cancer has increased from 034 to 044 for birth cohorts born in 1948-52 and 1978-82, respectively The increase in lifetime risk may be attributed to: early detection of cancer, lower mortality due to causes other than cancer, the increasing life expectancy over time, and possibly changes in the prevalence of cancer risk factors over time 21 of 22

Selected References Ahmad, A, Ormiston-Smith, N and Sasieni, P 2015 Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960 British Journal of Cancer, 112, 943947 Sasieni, P, Shelton, J, Ormiston-Smith, N, Thomson, C and Silcocks, P 2011 What is the lifetime risk of developing cancer? : the effect of adjusting for multiple primaries British Journal of Cancer, 105, 460-465 22 of 22